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Malaria is a highly prevalent disease caused by infec-
tion by Plasmodium spp., which infect hepatocytes
and erythrocytes. Blood-stage infections cause
devastating symptoms and can persist for years.
Antibodies and CD4+ T cells are thought to protect
against blood-stage infections. However, there has
been considerable difficulty in developing an effica-
cious malaria vaccine, highlighting our incomplete
understanding of immunity against this disease.
Here, we used an experimental rodent malaria model
to show that PD-1 mediates up to a 95% reduction in
numbers and functional capacity of parasite-specific
CD8+ T cells. Furthermore, in contrast to widely held
views, parasite-specific CD8+ T cells are required to
control both acute and chronic blood-stage disease
even when parasite-specific antibodies and CD4+
T cells are present. Our findings provide a molecular
explanation for chronicmalaria that will be relevant to
future malaria-vaccine design and may need consid-
eration when vaccine development for other infec-
tions is problematic.
INTRODUCTION
Malaria is a major cause of global morbidity and mortality. Peo-
ple living in endemic areas can develop partial immunity to this
disease, but only after repeated attacks of malaria, over several
years. This disease is caused by Plasmodium parasites, which
after introduction into the host by mosquitoes proceed to infect
hepatocytes followed by red blood cells (RBCs). It is the blood-1204 Cell Reports 5, 1204–1213, December 12, 2013 ª2013 The Autstage infection that causes the symptoms and lethality associ-
ated with malaria. The infection can also become chronic with
sustained, low levels of blood-stage parasites. These chronic in-
fections cause profound anemia and splenomegaly with severe
symptoms including mental depression and muscular weak-
ness. Drugs used to treat malaria are losing efficacy, and efforts
to develop an efficacious vaccine over 30 years have not been
successful.
The components of the immune system responsible for killing
Plasmodium parasites remain unclear, although antibodies are
known to have a key role in controlling blood-stage infections
(Cohen et al., 1961). In studies investigating the mechanism of
protection, mice deficient in mature B cells developed a chronic
relapsing parasitemia, confirming the need for antibodies to con-
trol chronic malaria (von der Weid et al., 1996). Furthermore,
studies in experimental rodent models showed that CD4+ Th1-
immune responses are also a critical component of protection
against chronic blood-stage malaria (Kumar and Miller, 1990;
Stephens and Langhorne, 2010; Su and Stevenson, 2002).
Finally, depletion of CD8+ T cells delayed clearance of
P. chabaudimalaria, implicating these cells in protection against
chronic disease (Podoba and Stevenson, 1991).
Signaling through the programmed death-1 (PD-1) receptor
is thought to ‘‘exhaust’’ HIV-specific CD4+ and CD8+ T cells
(Barber et al., 2006; Day et al., 2006; Freeman et al., 2006).
T cell exhaustion is characterized by poor effector function, sus-
tained expression of inhibitory receptors, and a transcriptional
state distinct from that of functional effector or memory T cells,
which prevent optimal control of infections and tumors (Wherry,
2011). Exhaustion can also lead to apoptosis of virus-specific
CD8+ T cells (Zhang et al., 2008).
Previous research implicated PD-1 in poor immune protection
against malaria. PD-1 was shown to be expressed by mouse
(Chandele et al., 2011; Hafalla et al., 2012) and human (Butlerhors
et al., 2012; Illingworth et al., 2013) CD4+ T cells during malaria,
suggesting lymphocyte-exhaustion in the pathogenesis of this
disease. Furthermore, blockade of PD-L1 augmented experi-
mental cerebral malaria (Hafalla et al., 2012). In contrast, com-
bined blockade of PD-L1 and lymphocyte-activation gene 3
(LAG-3) accelerated clearance of P. yoelii (nonchronic) malaria
and correlated with improved CD4+ T cell and B cell responses
(Butler et al., 2012). However, since PD-L1 can interact specif-
ically with both B7-1 (Butte et al., 2007) and PD-1 (Iwai et al.,
2003) to inhibit T cell activation, either or both (B7-1 and PD-1)
pathways could contribute to the attrition of malarial immunity.
Furthermore, the requirement for combined blockade of LAG-3
with PD-L1 to improve malarial immunity (Butler et al., 2012)
adds confusion to our understanding of any role for PD-1 per
se in inhibition of protection against malaria.
In the present study, we investigated whymalaria persists as a
chronic infection. We focused on (1) exhaustion of CD8+ T cell,
CD4+ T cell, and B cell responses; and (2) the direct role of
PD-1 in facilitating this process. We used a mouse model of
chronic malaria: Plasmodium chabaudi chabaudi AS (hereafter
referred to as P. chabaudi), which produces ongoing cycles of
recrudescent or low-grade infections that can persist for up to
3 months (Achtman et al., 2007). We found that parasite-specific
CD8+ T cells undergo significant PD-1-dependent exhaustion,
which exacerbates acute blood-stagemalaria and drives chronic
disease.
RESULTS
PD-1 Exacerbates Acute Blood-Stage Malaria and
Drives Chronic Infection
P. chabaudi parasites are detected in the blood of C57BL/6 (wild-
type [WT]) infected mice within 3–4 days postinfection (p.i.).
The parasitemia then peaks by day 7–10, rapidly clears by day
10–13, and is followed by a second peak that generally clears
around day 20–25 (acute phase). This is followed by the chronic
phase with low-level or recrudescent parasitemia, which can
occur at different times and levels in individual mice (Figure 1A).
Given that CD4+ T cells were implicated in protection against
chronic malaria, we first examined the durability of CD4+
T cell-mediated protection during P. chabaudi malaria (Figures
1B and 1C). We compared in vitro responses to total parasite
antigen extract by CD4+ T cells isolated from the spleens of in-
fected WT mice during acute (day 9 p.i.) and chronic (day 31
p.i.) malaria (Figure 1B). Approximately 11% of the CD4+
T cells proliferated in response to P. chabaudi antigens at day
9 p.i., but this percentage declined to 1% at day 31 (Figure 1B).
Similarly, the amount of interferon-g (IFN-g) secreted by CD4+
T cells declined by 30-fold betweendays 9 and 31p.i. (Figure 1C).
These results indicated that the numbers and functional capacity
of parasite-specific CD4+ T cells decline with ongoing infection.
Next, we explored how CD4+ T cells might lose their functional
capacity over the course of infection. For this, we examined
expression of PD-1 and CD11a (which identifies antigen-experi-
enced T cells; Butler et al., 2012) on CD4+ and CD8+ T cells from
P. chabaudi-infected mice (Figures 1D and 1E). Compared to
CD4+ T cells in naive mice, the number of CD4+ T cells express-
ing both CD11a and PD-1 increased 10-fold within 14 days p.i.,Cell Rebut then declined significantly by day 35 p.i. (Figure 1D). Further-
more, the number of CD8+ T cells that expressed both CD11a
and PD-1 increased 86-fold within 14 days p.i., but then declined
to the levels found in naive mice by day 35 p.i. (Figure 1E). A pep-
tide/major histocompatibility complex (MHC) tetramer (Kb-F4),
consisting of parasite-specific peptide F4 (EIYIFTNI) (Lau et al.,
2011) in context with MHC class I-Kb, was then used to label
and track parasite-specific CD8+ T cells in WT and PD-1
knockout (KO) mice. Approximately 4% of CD8+CD62L
T cells (which represent effector or effector memory cells) in
WT mice were labeled with this tetramer by day 7 p.i., and
most of these cells also expressed CD11a (Figure 1F). This result
validated that CD11a expression by CD8+ T cells did identify
parasite-specific CD8+ T cells. Furthermore,20% of Kb-F4-tet-
ramer+CD8+ T cells in WT mice (day 7) expressed PD-1 (Fig-
ure 1G; 1.17% of 5.36% total tetramer+ cells), confirming that
parasite-specific CD8+ T cells expressed the exhaustion marker.
To explore whether expression of PD-1 affected the clear-
ance of malarial parasitemia, we examined the outcome of
P. chabaudi infections in PD-1-deficient C57BL/6 mice
(Pdcd1/; hereafter referred to as PD-1 KO mice; Nishimura
et al., 2001). As shown in Figure 1H, the first peak in parasitemia
at day 7 p.i. was >2-fold lower (note log scale) in PD-1 KO mice
(20%) compared to WT animals (45%). PD-1 KO mice also
cleared acute parasitemia 7 days earlier than WT mice (arrow
in Figure 1H). After clearance of acute parasitemia, 100% of
WT mice continued to experience patent parasitemia. In marked
contrast, <30% of the PD-1 KO mice developed chronic infec-
tions, and parasitemia levels in these mice were >100-fold lower
than those in the WT mice. Importantly, by day 40, while all WT
mice experienced ongoing parasitemia, all PD-1 KO mice
(n = 5) had developed sterile immunity as the transfer of 200–
300 ml of their blood into naive mice did not transfer the infection.
Taken together, these results implicated PD-1 in a loss of capac-
ity to protect against malaria infections, thereby exacerbating
acute infections and delaying the clearance of parasites.
PD-1 on CD8+ and CD4+ T Cells Mediates Loss of
Capacity to Protect against Malaria
To address whether improved parasite control in PD-1 KO mice
was mediated by T cells, several cohorts of WT and PD-1 KO
mice were depleted of CD4+ or CD8+ T cells with specific anti-
bodies or treated with rat immunoglobulin (rIg) 1 day before
P. chabaudi infection and every 3–4 days until days 14–18 p.i..
WT mice receiving rIg (Figure 2A) had ongoing parasitemia at
day 32 unlike PD-1 KO mice (Figure 2B) that cleared acute para-
sitemia by day 25 (arrow). However, both WT (Figure 2C) and
PD-1 KOmice (Figure 2D), depleted of CD4+ T cells, were unable
to control parasitemia and died or had to be euthanized (Fig-
ure S1A) because they developed severe clinical symptoms
(Figures S1B and S1C). These observations demonstrated that
P. chabaudi-infected mice (both WT and PD-1 KO) required
CD4+ T cells to survive acute malaria.
Depletion of CD8+ T cells in WT mice had no significant effect
on acute (Figure 2E) or chronic parasitemia (Figure 2F) when
compared to rIg-treatment (Figure 2A). Chronic or recrudescent
peak parasitemia in individual mice are shown in scatterplots
to highlight differences in all mice. However, compared to rIgports 5, 1204–1213, December 12, 2013 ª2013 The Authors 1205
Figure 1. P. chabaudi AS Malaria Induces
PD-1 Expression on Parasite-Specific
CD4+ and CD8+ T Cells and PD-1 Dependent
Loss of Protection
(A) Mean percent parasitemia for a typical course
of infection in a cohort of mice infected with
P. chabaudi and monitored for 40 days.
(B) In vitro proliferation of CD3+CD4+ T cells in
response to total parasite antigen, as shown by
the uptake of EdU on days 9 (D9) and 31 (D31) p.i.
(C) IFN-g secretion by CD3+CD4+ T cells in
response to total parasite antigen on D9 and
D31 p.i.
(D) Flow cytometric profiles of Plasmodium infec-
tion-induced expression of PD-1 and CD11a on
CD4+ T cells at days 0 and 35 (D0 and D35). (The
line chart summarizes pooled data from 3 inde-
pendent experiments (total n = 9 mice). Error bars
represent SEM (**p < 0.005).
(E) Flow cytometric profiles of Plasmodium infec-
tion-induced expression of PD-1 and CD11a on
CD8+ T cells at D0 and D35. The line chart sum-
marizes pooled data from two independent ex-
periments (total n = 6 mice). Error bars represent
SEM (**p < 0.005).
(F) Flow cytometric profiles of CD11a and para-
site-specific tetramer labeling of CD8+CD62L
T cells from WT mice on day 7 p.i.
(G) Flow cytometric profiles of CD8+CD62L
T cells labeled with PD-1 and parasite-specific
tetramers.
(H) Mean percent parasitemia for a typical course
of infection in cohorts of WT and PD-1 KO mice
infected with P. chabaudi. The arrows represent
end of acute malaria PD-1 KO mice. Data repre-
sent five mice for this experiment with a total of 26
mice for all experiments (***p < 0.0001 between
WT and PD-1 KO groups, during peak para-
sitemia). Error bars represent SEM. Data represent
one of five independent experiments, using
groups of three, five, or six mice, for which similar
results were obtained.treatment (Figure 2B), depletion of CD8+ T cells in PD-1 KOmice,
increased peak parasitemia by 2-fold (p < 0.01) during the acute
phase of infection (Figure 2G). Furthermore, 100% of the PD-1
KO mice developed chronic malaria when depleted of CD8+
T cells (Figure 2H), compared to only 33% of rIg-treated PD-1
KO mice (Figure 2H). Critically, parasitemia levels in CD8+
T-cell-depleted PD-1 KO mice were significantly higher than
rIg-treated PD-1 KO mice (Figure 2H), similar to those of WT
animals (Figure 2F). Taken together, these findings showed
that PD-1 mediated a loss of CD8+ T cells in WT mice, which
were required to control acute and chronic malaria.1206 Cell Reports 5, 1204–1213, December 12, 2013 ª2013 The AuthorsFinally, to directly test CD8+ T-cell-
mediated protection against chronic ma-
laria, CD8+ T cells were purified from WT
and PD-1 KO mice, which were infected
21 days earlier, and transferred into in-
fected recipient WT mice at day 21 p.i.
(Figures 2I and 2J). Donor CD8+ T cellstaken from infected WT mice showed minor protection on the
course of recrudescent parasitemia in the recipient mice, for
6 days only (Figure 2I). By contrast, the CD8+ T cells derived
from infected-PD-1 KOmice profoundly controlled recrudescent
infections for 16 days (Figure 2J). The donor CD8+ T cells were
also assessed for parasite specificity by measuring IFN-g pro-
duction in response to parasite-specific (F4) peptide (Fig-
ure S2A). CD8+ T cells from PD-1 KO mice had nearly 3-fold
more IFN-g-secreting, parasite-peptide-specific CD8+ T cells
than WT mice, which explained the better protection seen in
recipients. Taken together, these data provide further support
Figure 2. CD4+ and CD8+ T Cell Depletion
and CD8+ T Cell Transfer Studies Show the
Role of These Cells in Protection Against
Acute and Chronic Malaria
(A–H) Mean percent parasitemia in WT (open
symbols) and PD-1 KO (closed symbol) mice
following treatment with rIg or the depletion of
CD4+ T cells or CD8+ T cells (y denotes the median
point of death). Data represent one of three inde-
pendent experiments in WT (total n = 11 mice) or
PD-1 KO (total n = 12) mice. Arrow shows when
PD-1 KO mice given rIg cleared acute infection
(*p < 0.01). (F and H) The scatterplots show peak
parasitemia during recrudescent or chronic ma-
laria in individual mice. The scatterplots represent
data from three pooled experiments and the bar
represents the median of peak parasitemia.
(I and J) Mean percent parasitemia in P. chabaudi-
infected WT mice following transfusion at day 21
p.i. with 33 105 CD8+ T cells fromWT or PD-1 KO
mice at day 21 p.i. The arrows indicate the day on
which CD8+ T cells were transferred. The data
represent one of three independent experiments
(n = 4 or 5), twice with 3 3 105 and once with 3 3
106CD8+ T cells permouse. Data are presented as
the mean % parasitemia ± SEM.for the above findings that CD8+ T cells protect against the
chronic phase of malaria and that PD-1 reduced the capacity
of these cells to protect against chronic disease.
PD-1 Mediates Loss of Parasite-Specific CD8+ T Cell
Numbers and Function during Malaria
To determine the extent to which PD-1 mediated exhaustion
of CD8+ T cells, WT and PD-1 KO mice were infected with
P. chabaudi and their CD8+ T cells were analyzed for numbers
and immune function, over 35 days. Total numbers of
CD3+CD8+ T cells were similar in WT and PD-1 KO mice and
did not change significantly over the course of infection (Fig-
ure 3A). Furthermore, the number of tetramer+CD8+CD62L
T cells at day 7 p.i. inWT and PD-1 KOmicewas also similar (Fig-
ure 3B). However, by day 35, PD-1 KO mice had 5-fold more
parasite-specific CD8+ effector or effector memory T cells than
WT mice (Figure 3B). We next examined CD8+CD62L+/ T cells
for expression of Ki-67, a marker of recent cell proliferation (Fig-
ure S2B). On the basis of Ki-67 expression, the proliferation of
CD8+CD62L T cells (Figure 3C) and CD8+CD62L+Ki-67+
T cells (Figure S2C) was similar in WT and PD-1 KO mice from
days 0 to 21. However, between days 21 and 35, WT mice lost
CD8+CD62LKi-67+ T cells, whereas these were maintained in
the PD-1 KO mice (Figure 3C). In agreement with these data,
CD8+ T cells from WT and PD-1 KO mice showed similar
in vitro proliferation activity in response to parasite proteins on
day 14 (Figure 3D), but by day 35 p.i., CD8+ T cells from PD-1Cell Reports 5, 1204–1213, DeKO mice had a significantly greater
capacity to proliferate (Figure 3D). Taken
together, the data showed that PD-1-
mediated 80% reduction in numbers of
tetramer+CD8+CD62L T cells and 95%
reduction in capacity of CD8+ cells to proliferate in response to
parasites during the chronic phase of malaria.
Next, we assessed cytokine responses. WT and PD-1 KO
mice had similar numbers of IFN-g-secreting CD8+CD62L
T cells at day 7 p.i.; however, the WTmice then showed a steady
decline in the number of these cells, whereas there was no
obvious change in PD-1 KO mice (Figure 3E). Furthermore, the
number of parasite-specific IFN-g-secreting cells at 35 days
p.i., as determined by CD8+ T cells responding to parasite-spe-
cific peptide F4 in an enzyme-linked immunosorbent spot
(ELISPOT) assay, confirmed this finding (Figure 3F). In addition,
T-bet, a transcription factor required for CD8+ T cell effector
function (including IFN-g production), was present in similar pro-
portions of CD8+CD62L T cells inWT as in PD-1 KOmice at day
7 (Figure S2D) but in a significantly greater proportion in PD-1 KO
mice at day 35 (Figure S2E). In contrast, the number of inter-
leukin-10 (IL-10)-secreting CD8+CD62L T cells, which coun-
teract protective Th1 responses, was similar in both groups of
mice throughout the course of infection (Figure S2F). Taken
together, the data showed that based on numbers of tetra-
mer+CD8+ T cells/spleen (Figure 3B), 18% of parasite-specific
CD8+ T cells from PD-1 KO mice could respond to peptide F4
in culture, compared to only 11% from WT mice at day 35 (Fig-
ure 3F), indicating functional exhaustion of parasite-specific
CD8+ T cells in WT mice.
Finally, to determine if CD8+ T cells had the ability to mediate
protection by cytotoxicity, (activated) CD69+CD8+ T cells werecember 12, 2013 ª2013 The Authors 1207
Figure 3. A Phenotypic and Functional Analysis of CD8+ T Cells from P. chabaudi-Infected WT and PD-1 KO Mice over 35 Days
(A) Mean numbers of CD3+CD8+ T cells per spleen.
(B) Mean numbers of parasite-specific F4-tetramer+CD8+CD62L T cells per spleen at days 7 and 35 p.i.
(C) Mean numbers of CD8+CD62L T cells expressing Ki-67 per spleen.
(D) Mean numbers of CD8+ T cells (days 14 and 35 p.i.) that proliferated in culture in response to parasite antigen, in the presence of naive DCs, as measured by
EdU uptake.
(E) Mean numbers of ex vivo CD8+CD62L T cells per spleen that secreted IFN-g, as measured by a flow cytometry-based assay.
(F) Mean numbers of parasite-specific CD8+ T cells per spleen at 35 days p.i that secreted IFN-g in response to parasite-specific peptide F4 compared to cultures
without peptide, as measured by ELISPOT assay.
(G and H) Mean numbers of CD8+CD69+ T cells per spleen that expressed (G) GzB or (H) CD107a. Error bars represent SEM (*p < 0.05; **p < 0.005; ***p < 0.0005
between WT and PD-1 KO groups.).assessed for granzyme B (GzB) expression. WT and PD-1 KO
mice had similar numbers of GzB-expressing cells for 14 days
p.i.; however, over the following 21 days, the WT mice showed
a greater decline in numbers of these cells than PD-1 KO mice
(Figure 3G). In contrast, surface acquisition of CD107a, which in-
dicates recent degranulation or secretion of cytokines (e.g., IFN-
g or IL-10), increased similarly in both groups of mice over the
course of infection (Figure 3H). Taken together, these findings
showed that the pool of functional CD62LCD8+ T cells capable
of secreting IFN-g, expressing GzB, and proliferating in response
to parasite antigens was depleted in WT mice during the chronic
phase of blood-stage malaria and that this depletion was medi-
ated by PD-1.
PD-1 Mediates a Reduction of CD4+ T Cell Numbers and
Function during Chronic Malaria
To determine if CD4+ T cells experienced PD-1-mediated
exhaustion during chronic malaria, WT and PD-1 KO mice
were infected with P. chabaudi and their CD4+ T cells were
analyzed over the course of 35 days. Total numbers of
CD3+CD4+ T cells in the spleen were similar in WT and PD-1
KO mice over the course of infection (Figure 4A). Furthermore,
in both groups of mice, T-bet was predominantly expressed in
CD4+CD62L cells in similar proportions (Figure 4B), and both
groups had similar numbers of these cells per spleen up to day1208 Cell Reports 5, 1204–1213, December 12, 2013 ª2013 The Aut21 (Figure 4C). However, by day 35 p.i., PD-1 KOmice had signif-
icantly more CD4+CD62LT-bet+ T cells per spleen (Figure 4C).
In addition, ex vivo proliferation (as determined by Ki-67 expres-
sion) of CD4+CD62L (Figure 4D) and CD4+CD62L+ T cells (Fig-
ure S3A) was similar over the first 21 days of infection in both
groups. However, by day 35, WT mice had fewer proliferating
CD4+CD62LKi-67+ T cells than PD-1 KO animals (Figure 4D).
These data were then confirmed using an in vitro EdU-uptake
assay to measure proliferation in response to parasite antigens.
On day 35, PD-1 KO CD4+ T cells had significantly more
parasite-specific proliferative capacity than did WT CD4+
T cells (Figures 4E).
Analysis of CD4+ T cell function found that while numbers
of IFN-g-secreting CD4+CD62L T cells were significantly
different between WT and PD-1 KO mice on day 0, both
groups had similar numbers on day 14 p.i. and these numbers
declined by day 21 (Figure 4F). By day 35, only the PD-1 KO
mice responded to chronic malaria with an increase in
numbers of IFN-g-secreting CD4+CD62L T cells (Figure 4F).
Furthermore, using CD11a as a surrogate marker of antigen-
specific CD4+ T cells (Butler et al., 2012), we found similar
numbers at day 14 in WT and PD-1 KO mice but 2-fold higher
numbers in PD-1 KO mice by day 35 (Figure 4G). Further,
similar percentages of antigen-experienced CD4+ T cells
secreted IFN-g in WT and PD-1 KO mice at day 14, buthors
Figure 4. A Phenotypic and Functional Analysis of CD4+ T Cells from P. chabaudi-Infected WT and PD-1 KO Mice over 35 Days
(A) Mean numbers of CD3+CD4+ T cells per spleen.
(B) Flow cytometric profiles of CD3+CD4+ T cells expressing CD62L and T-bet.
(C) Mean numbers of T-bet-expressing CD4+CD62L T cells per spleen.
(D) Mean numbers of CD4+CD62L T cells expressing Ki-67 per spleen.
(E) Mean numbers of CD4+ T cells (day 35 p.i.) that proliferated in culture in response to parasite antigen in the presence of naive DCs, as measured by EdU
uptake.
(F) Mean numbers of ex vivo CD4+CD62L T cells per spleen that secreted IFN-g, as measured by a flow cytometry-based assay.
(G) Mean numbers of CD4+CD62L T cells expressing CD11a per spleen at days 14 and 35 p.i.
(H) Percentage of CD4+CD62LCD11a+ T cells that secreted IFN-g, as measured by a flow cytometry-based assay on days 14 and 35 p.i.
(I) Ex vivo secretion of IFN-g by CD4+ T cells in culture, in response to parasite antigen in the presence of naive DCs, at days 0 and 35 p.i.
(J) Ex vivo secretion of TNF-a by CD4+ T in culture, in response to parasite antigen in the presence of naive DCs, at day 35 p.i.
(K) Mean numbers of ex vivo CD4+CD62L T cells per spleen that secreted IL-10, as measured by a flow-cytometry-based assay.
(L) Mean numbers of CD4+CXCR5+BCL6+ TFH cells per spleen. Error bars represent SEM. The data represent one of two or three independent experiments that
had similar results (*p < 0.05, **p < 0.005, and ***p < 0.0005 between WT and PD-1 KO groups).with 3.2-fold higher percentages in PD-1 KO mice at day 35
(Figure 4H).
CD4+ T cells were then taken from naive and P. chabaudi-in-
fected WT and PD-1 KOmice (at day 35) and cultured with naive
dendritic cells (DCs), with and without P. chabaudi antigens
to measure parasite-specific cytokine responses. At day 0, in
both PD1 KO and WT mice, antigen-specific IFN-g responsesCell Rewere negligible and equivalent (Figure 4I). In contrast, by day
35, CD4+ T cells taken from WT mice secreted 2.4-fold less
IFN-g (Figure 4I) in response to parasite antigens than those
from PD-1 KO mice. Similarly, at day 35, CD4+ T cells taken
from WT mice also secreted 2-fold less tumor necrosis factor-
a (TNF-a) in response to parasite antigens than those from
PD-1 KO mice (Figure 4J). However, there were no differencesports 5, 1204–1213, December 12, 2013 ª2013 The Authors 1209
Figure 5. A Phenotypic and Functional Analysis of B Cells from P. chabaudi-Infected WT and PD-1 KO Mice
(A) Mean numbers of CD19+B220+ B cells per spleen.
(B) Flow cytometric profiles of CD19+B220+ B cells expressing CD38loGL7+ GC B cells at days 9 and 21 p.i.
(C) Mean numbers of CD19+B220+CD38loGL7+ GC B cells per spleen on days 9, 21, and 31 p.i.
(D) Mean percentages of IgM+ B cell follicles with PNA+ GCs as measured by microscopy on day 21 p.i.
(E) Mean numbers of CD19+B220+CD138+plasma cells per spleen at day 21 p.i.
(F) Mean titers of P. chabaudi-specific antibody in infected mice at days 21 p.i. Error bars represent SEM. The data represent pool of two independent
experiments that yielded similar results.in IL-10 production by CD4+CD62L T cells from the two groups
of mice (Figure 4K). Taken together, the data showed that PD-1
mediated a reduction in the capacity of parasite-specific CD4+
T cells to proliferate and to secrete IFN-g and TNF-a during
the chronic phase of malaria (day 35), indicating exhaustion of
these cells.
Finally, to determine if other T cell populations experienced
PD-1-mediated exhaustion during chronic malaria, we assessed
CD3, CD4, CXCR5, and BCL-6 expression to count follicular T
helper (TFH) cells. TFH are required to support the development
of germinal centers and memory B cells in the spleen and their
numbers were similar in PD-1 KO andWTmice during the course
of infection (Figure 4L). However, an examination of regulatory
T cells in both experimental groups found that infected PD-1
KO mice had higher proportions of both CD4+CD25+FoxP3+
regulatory T (Treg) cells (Figure S3B) and TFR cells (FoxP3
+ TFH;
Sage et al., 2013) than WTmice (Figure S3C). Overall, compared
with WT animals, PD-1 KO mice maintained superior effector1210 Cell Reports 5, 1204–1213, December 12, 2013 ª2013 The Autand regulatory CD4+ T cell function during the chronic phase of
malaria.
PD-1 Does Not Affect B Cell Responses during Malaria
Previous research has shown that mice deficient in mature B
cells can reduce a primary acute infection with P. chabaudi to
low levels but cannot eliminate the parasites (von der Weid
et al., 1996). Thus, we examined whether PD-1 mediated a
loss of B cell responses over the course of 31 days. Following
P. chabaudi infection, WT and PD-1 KO mice showed no signif-
icant differences in the number ofCD19+B220+Bcells (Figure 5A)
or CD19+B220+CD38loGL7+ germinal center B cells (Figures 5B
and 5C), as assessed by flow cytometry, or in the percentage
of germinal center cells in tissue sections expressing PNA
(a germinal center marker; Figure 5D). The number of
CD19+CD138+ plasma cells (Figure 5E) and the antibody titers
(Figure 5F) were also equivalent at 21 days p.i. Overall, PD-1
did not affect B cell responses against malaria.hors
DISCUSSION
Taken as a whole, our findings show PD-1-mediated losses in
numbers and functional capacity of parasite-specific CD8+
T cells during the acute phase of malaria, which exacerbates
the infection and drives chronic disease. Furthermore, PD-1
also modestly affects CD4+ T cell function during malaria but
does not affect primary B cell responses.
As described in the Introduction, previous research had shown
indirect links between PD-1 and CD4+ T cell exhaustion in the
pathogenesis of malaria. Furthermore, combined blockade of
PD-L1 and LAG-3 in P. yoelii-infected mice correlated with in-
creases in the numbers of TFH cells, germinal center (GC) B cells,
and titers of antibodies with accelerated parasite clearance
(Butler et al., 2012). However, given that PD-L1 can interact spe-
cifically with both PD-1 and B7-1, the role of PD-1 remained un-
clear. Furthermore, the role of CD8+ T cells in protection against
malaria was not investigated. In our studies using PD-1 KOmice,
we found that deletion of PD-1 substantially accelerated parasite
clearance and improved CD4+ T cell numbers and function.
However, even though PD-1 KO mice had more functional
CD4+ T cells than WT mice and similar titers of parasite-specific
antibodies, they still developed chronic malaria if CD8+ T cells
were depleted. These observations highlight the crucial role of
CD8+ T cells in protection against chronic malaria.
A role for CD8+ T cells in the clearance of chronic, blood-stage
malaria is not generally acknowledged. Naive mice transfused
with CD8+ T cells derived from mice that survived two succes-
sive bouts of P. yoelii infections (not a chronic form of malaria)
survived lethal malaria (Imai et al., 2010), similar to protection
seen previously (Mogil et al., 1987). Furthermore, depletion of
CD8+ T cells in WT mice during P. chabaudi infections delayed
the overall clearance of the infection, compared to nondepleted
animals (Podoba and Stevenson, 1991). Critically, we found that
WT mice experienced a significant loss in the numbers and
capacity of parasite-specific CD8+ T cells to protect against
chronic malaria. The PD-1-mediated loss of these cells is
probably the result of several factors, including an inability of
exhausted cells to respond to interleukin-7 and interleukin-15,
which regulate T cell homeostasis (Yi et al., 2010).
These studies have conclusively shown that CD8+ T cells
contribute to parasite clearance during acutemalaria and control
chronic disease. Parasite-specific CD8+ T cells were shown to
secrete IFN-g and express GzB. Secretion of IFN-g by CD8+
T cells indicates that protection is mediated by support to innate
cells (e.g., macrophages) to clear parasites. Furthermore, the
increase in GzB+CD69+CD8+ T cells during infection indicates
cytotoxic-mediated killing of parasite-infected cells. This would
only be applicable to clearance of infected reticulocytes, but
not mature red cells, which express MHC class I molecules
required by CD8+ T cells for recognition. This possibility is sup-
ported by a previous study that found that while P. chabaudi par-
asites had a preference for mature red cells early in the infection,
parasites could infect reticulocytes during periods of severe
immune pressure on the parasites such as peak parasitemia
and ensuing ‘‘crisis’’ phase (Taylor-Robinson and Phillips, 1994).
While PD-1 KO mice had significantly better T cell function
than WT mice, their B cell function was not improved, unlikeCell Rethe studies where combined blockade of PD-L1 and LAG-3
improved antibody responses (Butler et al., 2012). One likely
explanation for this apparent contradiction is that PD-1 KO
mice compared with WT mice had a significantly higher propor-
tion of TFR cells (Figure S3C). Regulatory TFR cells are known to
be suppressive in vitro and to limit the numbers of TFH cells and
GC B cells in vivo (Linterman et al., 2011). In addition, the
improvement in B cell immunity produced by the coblockade
of PD-L1 and LAG-3 (Butler et al., 2012), not observed in the
PD-1 KO mice, could be explained by the interruption of inhibi-
tory signals to LAG-3 on B cells (Kisielow et al., 2005) or PD-L1
signals to B7-1 on B cells.
In conclusion, we show that during chronic malaria, PD-1
mediates the loss and exhaustion of parasite-specific CD8+
T cells with some loss in the capacity of CD4+ T cells to func-
tion. T cell exhaustion affects protection against the parasite,
and an improvement in T cell function alone is sufficient to
control chronic malaria. Given the difficulties in developing
antibody-based malaria vaccines, the role of CD8+ T cells re-
quires consideration. Significantly, our data also provide ratio-
nale for considering CD8+ T cells as targets of future malaria
vaccines and may need consideration for other diseases where
vaccine development for chronic or prolonged infections is
problematic.
EXPERIMENTAL PROCEDURES
Further details are provided in the Supplemental Experimental Procedures.
Mice
Specific pathogen-free C57BL/6 (WT) mice were obtained from the Animal
Resources Centre. PD-1 KO (Pdcd1/) mice on a C57BL/6 background
were kindly provided by T. Honjo through the Riken BRC (Nishimura et al.,
2001). Mice were housed in the QIMR animal research facility, and all proce-
dures were approved and monitored by the QIMR Animal Ethics Committee.
Work was conducted under QIMR animal ethics approval number A0209-
622M in accordance with the ‘‘Australian code of practice for the care and
use of animals for scientific purposes’’ (Australian National Health and Medical
Research Council).
Parasitic Infection and Monitoring
Cohorts of WT or PD-1 KO mice were inoculated intravenously with 105 para-
sitized red blood cells (pRBCs) freshly obtained from C57BL/6 mice previously
infected with P. chabaudi chabaudi AS (P. chabaudi). Tail-tip blood films were
made every 1–2 days, stained using the Quick Dip modified Wright-Giemsa
stain (Thermo Fisher Scientific), and examined for parasitemia, for up to
60 days. The percentage of pRBCs was assessed by counting at least 300
RBCs during parasitemia >1% or 10,000 cells at other times. Mice were
monitored daily for anemia and physical symptoms of disease, including
posture (hunching), lack of activity, and fur texture. Mice were euthanized if
they showed signs of significant distress.
In Vivo Depletion of CD4+ and CD8+ T Cells
For the depletion of CD4+ or CD8+ T cells, intraperitoneal injections of anti-CD4
(500 mg; GK-1.5, Bio X Cell), anti-CD8b (500 mg; 53.5.8, Bio X Cell) or control rat
IgG (500 mg; Bio X Cell) were administered on day 1 and then every 3–4 days
for 14–18 days. Mice were infected on day 0.
Tetramer Labeling
Parasite-specific F4 epitopes (H-2Kb restricted) previously described for
P. berghei ANKA (Lau et al., 2011) and also present in P. chabaudi were
used to produce phycoerythrin-labeled Kb-F4-tetramers (Grotenbreg et al.,
2008). CD8+ T cells were labeled with these tetramers and a range of standardports 5, 1204–1213, December 12, 2013 ª2013 The Authors 1211
CD8+ T-cell-related molecules. Refer to the Supplemental Experimental
Procedures for expanded details.
In Vitro Analysis of T Cell Proliferation and Cytokine Secretion
CD4+ or CD8+ T cells were isolated from P. chabaudi-infected mice, and den-
dritic cells were isolated from naive mice (for use as antigen-presenting cells),
using a Dynabeads Untouched Mouse T cells or DC kit (Life Technologies) and
then immunomagnetically isolated using anti-mouse CD4, CD8, or CD11c
Micro Beads (Miltenyi Biotec). Approximately 2 3 105 T cells, from individual
mice, were cocultured with 2 3 104 DCs, with or without P. chabaudi antigen,
in 8–12 replicate wells, for 4 days. On day 3, 20 mM EdU (5-ethynyl-20-deoxy-
uridine; a nucleoside analog that is incorporated into replicating DNA) (Life
Technologies) was added to cultures. After 24 hr, EdU uptake was measured
with a Click-it EdU Kit (Life Technologies). In addition, the supernatants were
collected from parallel cultures of 106 T cells after 36 hr of culture (without
EdU) and analyzed for cytokine secretion using the BD Cytometric Bead Array
kit (BD Biosciences). Antigen-specific responses (proliferation and cytokine
secretion) were calculated by subtracting nonspecific responses (no antigen)
from responses in cultures with antigen. Assays to measure ex vivo secretion
of IFN-g and IL-10 by flow cytometry were purchased from Miltenyi Biotec.
ELISPOT Assay to Measure Peptide-Specific IFN-g Production
PVDF micro plates (Millipore) were coated according to the manufacturer’s
directions using the Mouse IFN-g ELISPOT Ready-Set-Go kit (eBioscience).
Spleen cells from infected mice were cultured in 8–12 wells per treatment
per sample in these plates with 20 mg/ml peptide F4 or no peptide as previously
described (Howland et al., 2013). After 36 hr, the plates were processed
according to the manufacturer’s instructions.
Isolation and Transfer of CD8+ T Cells
Cohorts of WT mice and PD-1 KOmice were infected with P. chabaudi. At day
21 p.i., CD8+ T cells were isolated from these mice (see above) and 33 105 or
3 3 106 cells were transferred intravenously into WT mice that had been
infected 21 days prior. These recipient micewere thenmonitored for the devel-
opment of recrudescent parasitemia and compared to control infected mice
that had not been administered CD8+ T cells. For this isolation, CD8+ T cells
were enriched from red-blood-cell-depleted spleen cells using a Dynabeads
Untouched Mouse T Cells kit (Life Technologies) and then immunomagneti-
cally isolated using anti-mouse CD8a (Ly-2) Micro Beads (Miltenyi Biotec).
The samples were rerun on the AutoMacs (Miltenyi Biotec) until a purity of
>98% was obtained.
Statistics
Except where otherwise noted, the data are shown as the mean ± SEM.
p values were determined using the nonparametric Mann-Whitney U test on
pooled data from replicate experiments, analyzed using GraphPad Prism 5.
SUPPLEMENTAL INFORMATION
Supplemental information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2013.11.002.
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